Awarded WHO fellowship for training on “Information, Education and Communication” at Sydney, Australia from 2nd March to 30th March 2002.

Attended Training on Ethical Issues in Clinical Trial at Thamassat University, Bangkok from 29th July – 2nd Aug. 2002.

Attended WHO PDT Meeting on Paromomycin Phase III clinical trial as temporary WHO Adviser at Bangkok, Thailand from 17th – 18th Feb, 2003.

Post doctoral studies in the field of Epidemiology with emphasis on HIV, under UCLA Fogarty International Training and Research Programme from March 26 and June 13, 2003 at Univ. of California, Los Angeles, Graduate division.

Attended the second meeting of Indian chapter on Drugs for Neglected Diseases as a part of Global Initiative on DNDi by MSF Geneva.31st Jan’04 – 01st Feb’04.

Attended 53rd Annual meeting of the American Society of Tropical Medicine & Hygiene (ASTMH) held at Miami, Florida, USA from 7th – 11th Nov., 2004 and received “Outstanding Clinical Investigator Award for Advancement of Paromomycin as Clinical trial in VL cases in Bihar” by the Institute of OneWorld Health (iOWH), San Francisco, USA
.

Attended “Third World Congress on Leishmaniasis” held in Palermo-Terrasini, Sicily, Italy from 10-15 April 2005 and delivered a lecture on “A Phase III multicenter, Randomized, Controlled, Clinical trial to assess the safety and efficacy of injectable paromomycin in patients with visceral leishmaniasis: Paediatric subset analysis and preliminary final results”.

Attended Principal Investigator meeting of Paromomycin drug trial, organized by Institute for OneWorld Health (iOWH), San Francisco, California, USA held on June 12 – 18, 2005 in London.

Attended Principal Investigators meeting of Paromomycin (Shorter duration) drug trial, organized by iOWH, , San Francisco, USA and The 54th ASTMH meeting in Washington DC, 10-15 Dec’2005.

Attended Principal Investigators meeting of Paromomycin phase IV drug trial, organized by iOWH, San Francisco, USA, in Atlanta from 12-15 Nov’2006.

Attended 55th ASTMH meeting held in Atlanta from 12-15 Nov’2006 and presented a paper entitled “HIV/VL co-infection: an Indian experience with special focus in Bihar”.

Attended PDT meeting of WHO/TDR on Miltefosine phase II drug trial in PKDL and Combination therapy, 15th Nov’2006 at Atlanta, GA, USA.

Attended 56th ASTMH meeting held in Philadelphia, USA from 3rd- 8th Nov’2007. Presented papers on i) “ Paromomycin IM Injection for the Treatment of Visceral Leishmaniasis”;ii) Oral sitamaquine compared with amphotericin B in the treatment of visceral leishmaniasis (VL) caused byL.donovani in endemic areas:Interim Day 90 efficacy/safety results

Attended PDT meeting of WHO/TDR on Miltefosine phase II drug trial in PKDL, ICMR/TDR sponsored Combination therapy, 7th Nov’2007 in Philadelphia,USA.

Attended training programme on ‘“Promoting Ethics and Science in Clinical Trials” sponsored by ‘Forum for Ethical Review Committees in the Asia and  Western Pacific Region, Thailand.” 21st – 23rd July’2008    Co-ordinator office: Rm 702 Building 8 , Department of Medical Science,Ministry of Public Health.Tiwanon Road, Nonthaburi,Thailand 11000.

Attended Third meeting of the Regional Technical Advisory Group (RTAG) of SEARO/WHO on Elimination of Kala azar, Dhaka, Bangladesh 8-11-December 2009.

Tenth National Congress of Parasitology, Dehradun, 16-18 March, Abst. No.-510

Meeting on PKDL Vaccine study – 29th Jan'04 at ICMR Hqr, New Delhi as Temporary Adviser

3. The second meeting of Indian chapter on Drugs for Neglected Diseases as a part of Global Initiative on DNDi by MSF Geneva.31st Jan'04 – 01st Feb'04.Patna